X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2015) 2015
Publication (428) 428
Book Chapter (25) 25
Book Review (14) 14
Conference Proceeding (6) 6
Government Document (5) 5
Dissertation (2) 2
Book / eBook (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1420) 1420
index medicus (1009) 1009
animals (866) 866
mice (558) 558
neurofibromin 1 - genetics (558) 558
mutation (548) 548
female (486) 486
male (450) 450
neurofibromatosis (449) 449
genetics & heredity (422) 422
neurofibromin 2 (399) 399
cell biology (388) 388
biochemistry & molecular biology (384) 384
oncology (365) 365
neurofibromatosis 1 - genetics (359) 359
neurofibromin 1 (353) 353
tumors (346) 346
neurofibromin 2 - genetics (341) 341
neurofibromin 2 - metabolism (304) 304
nf1 (299) 299
signal transduction (286) 286
neurofibromin 1 - metabolism (285) 285
expression (278) 278
adult (274) 274
article (274) 274
cancer (273) 273
merlin (259) 259
neurofibromin (251) 251
genetic aspects (245) 245
neurosciences (235) 235
congenital, hereditary, and neonatal diseases and abnormalities (224) 224
gene (218) 218
proteins (218) 218
molecular sequence data (207) 207
middle aged (206) 206
research (197) 197
phosphorylation (195) 195
analysis (188) 188
nervous system diseases (187) 187
growth (180) 180
mutations (180) 180
cells, cultured (177) 177
neurofibromatosis type 1 (173) 173
cell proliferation (172) 172
gene expression (169) 169
nf2 (169) 169
phenotype (169) 169
child (164) 164
clinical neurology (164) 164
neoplasms (162) 162
base sequence (161) 161
cell line, tumor (161) 161
genes (158) 158
membrane proteins - genetics (156) 156
tumor-suppressor (156) 156
adolescent (154) 154
ras (152) 152
cells (151) 151
identification (147) 147
neurofibromatosis 2 - genetics (146) 146
immunohistochemistry (143) 143
genes, neurofibromatosis 1 (139) 139
protein (137) 137
neurofibromatosis 1 - pathology (136) 136
mice, knockout (134) 134
multidisciplinary sciences (133) 133
activation (132) 132
genetics (132) 132
neurofibromatosis type-1 (132) 132
aged (131) 131
neurofibromatosis 2 (131) 131
pathology (129) 129
amino acid sequence (123) 123
nf1 gene (120) 120
proteins - genetics (120) 120
disease models, animal (119) 119
neurofibromatosis 1 - metabolism (119) 119
tumor suppressor genes (119) 119
neurofibromatosis type-2 (116) 116
gene-product (115) 115
membrane proteins - metabolism (112) 112
gene mutations (111) 111
research article (111) 111
dna mutational analysis (110) 110
cell line (107) 107
kinases (106) 106
mice, inbred c57bl (106) 106
protein binding (105) 105
genes, neurofibromatosis 2 (103) 103
rats (103) 103
schwann cells (103) 103
apoptosis (102) 102
gene deletion (102) 102
children (101) 101
gene expression regulation, neoplastic (100) 100
schwann-cells (100) 100
medicine (98) 98
polymerase chain reaction (98) 98
ras proteins - metabolism (98) 98
child, preschool (97) 97
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1989) 1989
Japanese (9) 9
Russian (9) 9
Chinese (7) 7
German (5) 5
French (4) 4
Turkish (4) 4
Italian (2) 2
Spanish (2) 2
Czech (1) 1
Dutch (1) 1
Hebrew (1) 1
Persian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2009, Volume 373, Issue 9679, pp. 1974 - 1986
Journal Article
Nature Neuroscience, ISSN 1097-6256, 04/2013, Volume 16, Issue 4, pp. 426 - 433
Journal Article
Head & Neck, ISSN 1043-3074, 10/2019, Volume 41, Issue 10, pp. 3612 - 3617
Background Neurofibromatosis type 2 (NF2) is an autosomal dominant, multiple neoplasia syndrome characterized by bilateral vestibular schwannomas (VSs).... 
neurofibromatosis type 2 | CD105 | endoglin | vestibular schwannoma | schwannoma growth rate | TARGET | SURGERY | HEAD | MANAGEMENT | BEVACIZUMAB | MARKER | THERAPY | OTORHINOLARYNGOLOGY | Cell proliferation | Growth rate | Image processing | Schwann cells | Neurofibromatosis 2 | Neurofibromin 2 | Endothelial cells | Angiogenesis | Endoglin | Magnetic resonance imaging | Neurofibromatosis | Vestibular system | CD105 antigen
Journal Article
PLoS ONE, ISSN 1932-6203, 06/2018, Volume 13, Issue 6, p. e0197350
Neurofibromatosis 2 (NF2) is a rare tumor suppressor syndrome that manifests with multiple schwannomas and meningiomas. There are no effective drug therapies... 
MOLECULE INHIBITOR | LAPATINIB | HISTONE DEACETYLASE INHIBITOR | ACTIVATION | MULTIDISCIPLINARY SCIENCES | THERAPEUTIC TARGET | PHASE-II | GROWTH-FACTOR | KINASE INHIBITOR | MENINGIOMA CELLS | VESTIBULAR SCHWANNOMAS | Neurofibromatosis 2 - drug therapy | Cell Survival - drug effects | Neurofibromin 2 - genetics | Meningeal Neoplasms - genetics | Humans | Panobinostat - pharmacology | Carcinogenesis - genetics | Gene Expression Regulation, Neoplastic | Morpholines - pharmacology | Transcriptome - genetics | Neurofibromatosis 2 - genetics | Pyrimidines - pharmacology | Sulfonamides - pharmacology | Systems Biology | Neurilemmoma - pathology | Quinolines - pharmacology | Neurofibromatosis 2 - pathology | Animals | Meningeal Neoplasms - drug therapy | Neurilemmoma - drug therapy | Neurilemmoma - genetics | Cell Line, Tumor | Mice | Meningeal Neoplasms - pathology | Genetic aspects | Drug discovery | Research | Drug therapy | Systems biology | Neurofibromatosis | Cell culture | Pediatrics | Neurofibromin 2 | Neurofibromatosis 2 | Biology | Kinases | Medical schools | Consortia | Tumorigenesis | Bioinformatics | Phenotypes | Schwann cells | Breast cancer | Gene expression | Medical screening | Molecular chains | Children & youth | Medicine | Hospitals | Tumor suppressor genes | Blood diseases | Viability | Meningioma | Tumors
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 06/2017, Volume 23, Issue 12, pp. e54 - e61
The neurofibromatoses consist of at least three autosomal-dominant inherited disorders: neurofibromatosis type 1 (NF1), neurofibromatosis type 2 (NF2), and... 
MENINGIOMAS | GENE | ONCOLOGY | SPLICE-SITE MUTATIONS | DISEASE SEVERITY | PRONE SYNDROMES | NF2 | DIAGNOSTIC-CRITERIA | VESTIBULAR-SCHWANNOMA | TYPE-2 NEUROFIBROMATOSIS | FAMILY | Neurofibromin 2 - genetics | Humans | SMARCB1 Protein - genetics | Meningioma - genetics | Neurofibromatoses - genetics | Neurilemmoma - genetics | Meningioma - epidemiology | Skin Neoplasms - diagnosis | Child | Skin Neoplasms - diagnostic imaging | Genetic Predisposition to Disease | Meningioma - diagnostic imaging | Neurofibromatoses - diagnosis | Neurilemmoma - epidemiology | Neurilemmoma - diagnostic imaging | Transcription Factors - genetics | DNA-Binding Proteins - genetics | Skin Neoplasms - epidemiology | Chromosomal Proteins, Non-Histone - genetics | Magnetic Resonance Imaging | Neurofibromatoses - epidemiology | Skin Neoplasms - genetics | Adolescent | Meningioma - diagnosis | Neurofibromin 1 - genetics | Neurofibromatoses - diagnostic imaging | Neurilemmoma - diagnosis | Neuroimaging | Brain | Pediatrics | Central nervous system | Disorders | Neurofibromin 2 | Neurofibromatosis 2 | Nervous system | Malignancy | Risk factors | Vestibular system | Children | Localization | Chromosome 17 | Image resolution | Schwann cells | Recklinghausen's disease | Hereditary diseases | Magnetic resonance imaging | Surveillance | Neurofibromatosis | Chromosome 22 | Meningioma | Tumors | Cancer
Journal Article
Clinical Genetics, ISSN 0009-9163, 01/2018, Volume 93, Issue 1, pp. 187 - 190
A 28‐year‐old female with PIK3CA‐related segmental overgrowth presented with headaches. She also had a unilateral vestibular schwannoma (VS), as well as 3... 
mosaic | neurofibromatosis | NF2 | PIK3CA | overgrowth | CRITERIA | MARMORATA TELANGIECTATICA CONGENITA | GENETICS & HEREDITY | CUTIS MARMORATA | SPECTRUM | Acoustic neuroma | Analysis | Headache | Neurofibromatosis | Genetic analysis | Schwann cells | Neurofibromin 2 | Neurofibromatosis 2 | Mosaicism | Vestibular system | Diagnosis | Mutation
Journal Article
Journal Article
Journal Article
Archives of Disease in Childhood, ISSN 0003-9888, 05/2018, Volume 103, Issue 5, pp. 463 - 469
Journal Article